Detail akcie BlRc Hlt Sci II online

Business Summary: BlackRock Health Sciences Term Trust (the Trust) is a closed-end management investment trust. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. Trust may also invest in companies of any market capitalization located anywhere in the world, including companies located in emerging markets. The Trust focuses on small and mid-sized healthcare companies. The Trust invests in industries, such as biotechnology, life sciences tools and services, pharmaceuticals, financial services, health care technology, hotels, restaurants and leisure, and others. The Trust’s investment adviser is BlackRock Advisors, LLC.
Financial Summary: BRIEF: For the six months ended 30 June 2025, BlackRock Health Sciences Term Trust revenues decreased 19% to $4.7M. Net loss totaled $62.5M vs. income of $29.7M. Revenues reflect Dividends unaffiliated decrease of 34% to $3.3M, Foreign taxes withheld decrease of 48% to -$272K, Securities lending income affiliated n decrease of 45% to $29K. Net loss reflects Net realized gain (loss) from: Investmen decrease from $8.3M (income) to $59.2M (expense).